Stay updated on Pembrolizumab in Advanced Head and Neck Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Advanced Head and Neck Clinical Trial page.

Latest updates to the Pembrolizumab in Advanced Head and Neck Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedExpanded the Locations section with a comprehensive, multi-country list of trial sites, including numerous U.S. states and international regions.SummaryDifference3%

- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedPublications section updated to state that these publications are automatically filled in from PubMed and may not necessarily be about the study; revision tag updated from v3.2.0 to v3.3.2, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check52 days agoChange DetectedRemoved the government funding/operating status notice from the page. The study details and other content remain unchanged.SummaryDifference0.1%

- Check59 days agoChange DetectedThe Taiwan site entry changed from 'Tainan City, Taiwan, 704' to 'Tainan, Taiwan, 704' to standardize the city naming in the location list.SummaryDifference0.0%

- Check74 days agoChange DetectedThe Colombia location entry was updated to replace Santiago de Cali with Cali in Valle del Cauca Department, Colombia (760042).SummaryDifference0.2%

- Check95 days agoChange Detected- Added a prominent notice about potential data and processing delays due to funding lapse and updated operating status guidance, and a new version tag v3.2.0. - Removed the previous version tag v3.1.0.SummaryDifference0.6%

Stay in the know with updates to Pembrolizumab in Advanced Head and Neck Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced Head and Neck Clinical Trial page.